Drug Database
Back to search

Iceland· IS-EU/1/15/1008/001

Hetlioz

A tasimelteon product containing tasimelteonum inn, registered in Iceland by Vanda Pharmaceuticals Netherlands B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC N05CH03

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedHetliozATCN05CH03REGISTER NO.IS-EU/1/15/1008/001PACKS LISTED0CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tasimelteonum innAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tasimelteon is registered in 9 of 19 countries.

Countries holding a registration under ATC N05CH03 (tasimelteon), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 6 of them publish a price we can compare per daily dose
Search tasimelteon products by name

Tasimelteon · ATC N05CH03

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Tasimelteonum INN
Manufacturer
Vanda Pharmaceuticals Netherlands B.V.
Country
Iceland (IS)
ATC code
N05CH03
ATC class
Tasimelteon
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

132 interactions on record for tasimelteon.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tasimelteon against other medicinesHow interaction checks work

Tasimelteon · interactions on record

132 records

  • 7 severe
  • 125 moderate

Most severe, free to view

  • MitotaneL01XX23severe
  • EnzalutamideL02BB04severe
  • ApalutamideL02BB05severe
  • MorphineN02AA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tasimelteon in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tasimelteon products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Liechtenstein · Hetlioz
  • Norway · Hetlioz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/70282068-c081-4f9e-b0ea-5ffd110d9a0e
GET /v1/drugs/70282068-c081-4f9e-b0ea-5ffd110d9a0e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Hart hylki",
  "source": "lyfjastofnun",
  "atc_raw": "N05CH03",
  "marketed": false,
  "strength": "20 mg",
  "ma_number": "EU/1/15/1008/001",
  "substance": "Tasimelteonum INN",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "42188"
}
API referenceMCP serverPlans

See everything about tasimelteon.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console